Incidence, Risk Factors, and Outcomes of Stroke Following Cardiac Transplantation
Stroke 52:e720-e724, Alnsasra, H.,et al, 2021
Heart Transplantation in a Patient with Myotonic Dystrophy Type 1 and End-Stage Dilated Cardiomyopathy: A Short Term Follow-up
Acta Myologica 37:267-271, Papa, A.A.,et al, 2018
Progressive Multifocal Leukoencephalopathy in Transplant Recipients
Ann Neurol 70:305-322, Mateen, F.J.,et al, 2011
Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients
Medicine 89:166-175, Mu�oz,P., et al, 2010
Effect of Neurologic Complications on Outcome After Heart Transplant
Arch Neurol 65:226-231, van de Beek,D.,et al, 2008
Treatment of End Stage Dilated Cardiomyopathy
Br Heart J 72:S52-S56, O'Connell,J.B.,et al, 1996
Neurologic Complications of Pediatric Heart Transplantation
Arch Pediatr Adolesc Med 148:973-979, Lynch,B.J.,et al, 1994
Neurological Complications of Organ Transplantation
Ann Neurol 36:688-703, Patchell,R.A., 1994
Cerebrovascular Syndromes Following Cardiac Transplantation
Neurol 42:819-823, Adair,J.C.,et al, 1992
Cardiac Transplantation in a Patient with Muscular Dystrophy and Cardiomyopathy
Arch Neurol 46:705-707, Donofrio,P.D.,et al, 1989
Spectrum of Neurologic Events Following Cardiac Transplantation
Stroke 20:1586-1589, Sila,C.A., 1989
Neuropathology of Heart Transplantation:23 Cases
Neurol 36:1149-1154, Montero,C.G.&Martinez,A.J., 1986
Rapid Development of Myelopathy after HTLV-1 Infection Acquired by Transfusion During Cardiac Transplantation
NEJM 322:383-387, Gout,O.,et al, 1990
Cyclosporine-Related Central Nervous System Toxicity in Cardiac Transplantation
NEJM 323:420-421, Hughes,R.L., 1990